Mark N. Lampert, Director: Kymera Therapeutics KYMR Sell · Filed 06/26

Trade details

Type: Insider sale
Amount: $5,522,877
Shares · price: 51,858 sh · $106.50 a share
Held after: 78,787 sh
Stock: Kymera Therapeutics KYMR
Person: Mark N. LampertDirector
Trade date: 26/06/26
Filed: 26/06/26
Days to filing: 0 days

Sold 39.7% of holdings

Share of holding sold: 39.7%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 05/27~07/26

Mark N. Lampert's recent trades

Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$32.4M
1,932,354 sh
$32.4M
Filed 04/02
Traded 03/31
Mark N. LampertDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$26.3M
1,569,116 sh
$26.3M
Filed 04/02
Traded 03/31